Trademarkia Logo

Australia

AU$
SYMVICTI
Cancelled: Cancelled at the request of IB

Last updated on 22 Mar 2018

Owner Info

Syndax Pharmaceuticals, Inc.

400 Totten Pond Road, Suite 110

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

1702711 filed on 22 Jan 2015

Correspondent

Jennifer M. Lantz, Hogan Lovells US LLP

4085 Campbell Avenue, Suite 100,

Menlo Park CA 94025,

UNITED STATES OF AMERICA

SYMVICTI

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer

Class [042]
Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment

Mark Details


Serial Number

1702711

Registered On

22 Jan 2015

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Nov 2014

Mark Type

US

Legal History


Show more

Status DateAction Taken
22nd Mar 2018Cancellation of Entry in Register Published
13th Mar 2018Cancel IP Right
14th Dec 2017General Correspondence (Application or Registration)
8th Oct 2015IP Right Registration Published
1st Oct 2015Register Trade Mark
1st Oct 2015Application Status
23rd Jul 2015IP Right Acceptance Published
14th Jul 2015Clear Examination report approved
14th Jul 2015User Created Notice correspondence sent
14th Jul 2015Application Accepted correspondence sent